Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia

Oral Glutamine for the Prevention of Chemotherapy-Induced Peripheral Neuropathy

(2008) Shilpa Amara   ANNALS OF PHARMACOTHERAPY

Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia

(2008) A. M. Roccaro et al.   BLOOD

Molecular basis of bortezomib resistance: proteasome subunit  5 (PSMB5) gene mutation and overexpression of PSMB5 protein

(2008) R. Oerlemans et al.   BLOOD

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature

(2008) A. A. Argyriou et al.   BLOOD

Proteasome   Subunit Pharmacogenomics: Gene Resequencing and Functional Genomics

(2008) L. Wang et al.   CLINICAL CANCER RESEARCH

Treatment of light chain deposition disease with bortezomib and dexamethasone

(2008) E. Kastritis et al.   HAEMATOLOGICA

Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease

(2008) A. D. Wechalekar et al.   HAEMATOLOGICA

Chemotherapy-induced neuropathy

(2008) Anthony J. Windebank et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE